WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing a category

Search
Enter keywords, a title or a report id number below.
Advanced

• SELECT SITE CURRENCY

Select a currency for use throughout the site



Genomics

The term Genomics refer to a branch of molecular biology which studies structure, function, evolution, and mapping of genomes. This discipline has a wide range of practical applications in food, agriculture, technology, medicine: it is a dynamic science, far-reaching and abundant with research and business opportunities.

The reports listed under Research and Markets’ Genomics category cover every aspect of commercial genetic activity, including DNA sequencing, gene mining, functional genomics, population-based genomics, bioinformatics, gene therapy, and pharmaceutical and biopharmaceutical concerns. You will find information regarding technologies, products and techniques on the market; R&D and product development; manufacturing statistics; market share and regional/national profiles.

Also available is a selection of scientific texts from acclaimed academics and experts, catering for the needs of a wide readership ranging from undergraduate students to top researchers worldwide. Show Less
... more

Sort by

Sorted by Date Published
  • 09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

    Life Science Intelligence, Sep 2012
    This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in September 2012 All companies include technology, market(s), key...
  • US Personalized Cancer Genome Sequencing Market

    RNCOS E-Services Private Limited, Sep 2012 , Pages: 55
    The US personalized cancer Whole-Genome Sequencing market is primarily classified into targeted genome sequencing and Whole-Genome Sequencing Our report entitled “US Personalized Cancer Genome Sequencing...
  • 08 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

    Life Science Intelligence, Aug 2012
    This report includes details on 28 emerging medical technology companies that have been identified by LSI's in-house research team in August 2012 All companies include technology, market(s), key executive,...
  • Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets

    GBI Research, Jul 2012 , Pages: 75
    GBI Research, a leading business intelligence provider, has released its latest research, entitled “Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber...
  • 07 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

    Life Science Intelligence, Jul 2012
    This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in July 2012 All companies include technology, market(s), key executive,...
  • 06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

    Life Science Intelligence, Jun 2012 , Pages: 40
    This report includes details on 39 emerging medical technology companies that have been identified by LSI's in-house research team in June 2012 All companies include technology, market(s), key executive,...
  • Genomic Pathology

    Future Medicine Ltd, May 2012 , Pages: 117
    The May 2012 (9[3]) issue of Personalized Medicine focuses on the topic of genomic pathology and is guest edited by Dr Dennis P Wall and Dr Peter J Tonellato (Beth Israel Deaconess Medical Center, Harvard...
  • 05 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

    Life Science Intelligence, May 2012 , Pages: 45
    This report includes details on 41 emerging medical technology companies that have been identified by LSI's in-house research team in May 2012 All companies include technology, market(s), key executive,...
  • Gene Expression Profiling Life Science Dashboard™ Series 4

    Percepta Associates Inc, Apr 2012 , Pages: 218
    Gene expression profiling methods enable the quantification of multiple transcripts from a single RNA sample Powerful and continually evolving methods, such as short-read sequencing (RNA-seq), microarray...
  • 04- 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

    Life Science Intelligence, Apr 2012 , Pages: 38
    This report includes details on 37 emerging medical technology companies that have been identified by LSI's in-house research team in April 2012 All companies include technology, market(s), key executive,...
  • 03 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

    Life Science Intelligence, Mar 2012 , Pages: 81
    This report includes details on 61 emerging medical technology companies that have been identified by LSI's in-house research team in March 2012 All companies include technology, market(s), key executive,...
  • Analysis of MicroRNA Tools and Services Market in Europe

    Frost & Sullivan, Feb 2012 , Pages: 135
    This Frost & Sullivan research titled Analysis of MicroRNA Tools and Services Market in Europe starts from the base year of 2010 with forecasts running through 2017 It offers a comprehensive market...
  • 02 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

    Life Science Intelligence, Feb 2012 , Pages: 95
    This report includes details on 43 emerging medical technology companies that have been identified by LSI's in-house research team in February 2012 All companies include technology, market(s), key executive,...
  • Global Genetic Testing Market Analysis

    RNCOS E-Services Private Limited, Jan 2012 , Pages: 65
    As the foundation of providing superior healthcare lies in diagnosis, genetic testing represents a highly attractive segment in molecular diagnostics market Genetic testing is a sophisticated form of...
  • Strategic Analysis of the U.S. Next-Generation Sequencing Services Market

    Frost & Sullivan, Nov 2011 , Pages: 76
    This Frost & Sullivan research service titled Strategic Analysis of the U S Next-Generation Sequencing Services Market provides analysis of trends, drivers and restraints, products, competitors and...
  • Epigenetics: Principles of Eukaryotic Genome Control

    John Wiley and Sons Ltd, Jul 2011 , Pages: 256
    Epigenetics: Principles of Eukaryotic Genome Control provides an integration of classical and molecular genetic perspectives to highlight underlying principles of gene and genome control in eukaryotes,...
  • Epigenetics Market Trends 2011

    Select Biosciences Ltd, Jan 2011 , Pages: 76
    This is the latest and most up-to-date Market Report addressing the expanding epigenetics marketplace Epigenetics research efforts are growing around the world driven by the numerous documented associations...
  • CuraGen Corporation - SWOT Framework Analysis

    Aruvian's R'search, Jul 2010 , Pages: 20
    SWOT Analysis, is a strategic planning tool used to evaluate the Strengths, Weaknesses, Opportunities, and Threats involved in a project or in a business venture. It involves specifying the objective...
  • Whey Proteins - Global Strategic Business Report

    Global Industry Analysts, Inc, Jun 2010 , Pages: 177
    This report analyzes the US and European Markets for Whey Proteins in US$ Million The US market is also analyzed by volume (Million Pounds (lbs)) The US market is further analyzed by the following product...
  • Genomics, Proteomics and Metabolomics in Diagnostics: Market Landscape, Innovative Technologies and Future Outlook

    Scripp Business Insights, Mar 2010 , Pages: 185
    The key factor in the current scenario for next-generation omics-based diagnostic technologies is the level of accuracy in the results, followed by the capacity to detect early, and cost Cost currently...
  • Gene Expression Profiling Life Science Dashboard Series 3

    Percepta Associates Inc, Feb 2010 , Pages: 162
    Gene expression profiling methods enable the quantification of multiple transcripts from a single RNA sample Powerful and continually evolving methods, such as microarray analysis, multiplex PCR and...
  • Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma

    GBI Research, Feb 2010 , Pages: 89
    “Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma” provides insights into the unmet needs in the pharmaceutical and healthcare market and potential segments where...
  • The Future of Nutrigenomics: New Opportunities in Personalized Nutrition and Food-pharma Collaboration

    Scripp Business Insights, Jan 2010 , Pages: 151
    Nutrigenomics explores how nutrients or bioactive dietary compounds can influence gene expression and an individuals risk to certain diseases Nutrigenetics is the study of how variations in an individual’s...
  • DNA Sequencing In Drug Discovery: Market Outlook for Applications, Tools and Services, and 40 Company Profiles

    Scripp Business Insights, Jan 2010 , Pages: 179
    The advent of DNA sequencing technology has had a vast impact on the field of drug development It has played a key role in the success of the Human Genome Project which has made it an essential tool...
  • Innovations In Epigenetics: Advances in Technologies, Diagnostics & Therapeutics

    Scripp Business Insights, Nov 2009 , Pages: 165
    The study of epigenetics - changes in gene expression that occur without a change in a cell’s DNA code – is becoming increasingly important as scientists explore how internal and external factors trigger...
  • Personal Genomics

    Future Medicine Ltd, Nov 2009 , Pages: 96
    The use of individual human genome sequence information has passed the threshold of basic experimentation and speculation, and has entered the early stages of clinical research and diagnostics, beginning...
  • MicroRNA Research Trends 2009 Market Report

    Select Biosciences Ltd, Jul 2009 , Pages: 134
    This is the latest and most up-to-date market analysis report addressing microRNA research market trends The focus of this report is to document the technical and commercial trends operative in the...
  • Competitor Analysis: CD20 Antibodies

    La Merie Publishing, Jan 2009 , Pages: 37
    The present Competitive Intelligence Report about anti-CD20 antibodies used to treat B-cell mediated malignancies and rheumatoid arthritis provides a competitor evaluation in the field of R&D projects...
  • Biopharmaceutical Expression Systems and Genetic Engineering Technology

    Bioplan Associates Inc, Nov 2008 , Pages: 415
    New expression systems and recent improvements available for current systems have the potential to revolutionize the biopharmaceutical industry!Lower costs and efficiencies of newer expression systems...
  • Ethical Issues in Governing Biobanks

    Ashgate Publishing, Nov 2008 , Pages: 268
    Population genomics research drawing on genetic databases has expanded rapidly, with some of this information being combined in 'biobanks' Managing this information in an appropriate way is a highly...
  • The Survey of Gene Modified (GM) Crops in China

    CCM International Limited, Oct 2008 , Pages: 26
    Genetically modified (GM) crops are one of the major fields of glyphosate use in the world In 2008, Chinese government approved the commercial production of four kinds of GM crops, which shows that...
  • Telecommunication Equipment Market 2007-2010

    Infiniti Research Limited, Jul 2008 , Pages: 19
    Telecom carriers continue to shift their capital expenditure to next-generation infrastructure and technologies that offer the proposition of revenue growth or of lowering operating expenses. Further,...
  • Genomics World Markets

    TriMark Publications, May 2008 , Pages: 160
    Genomics is transforming the pharmaceutical industry Companies are moving from drug discovery and development based on medicinal chemistry to the design of drugs based on information provided by genomics...
  • How to Get Ahead with Pharmacogenomics

    Decision Resources, Inc, Mar 2008 , Pages: 42
    Introduction Pharmacogenomics (PGx) is an evolutionary—not a revolutionary—process The “blockbuster” business model is, of course, still relevant to the pharmaceutical industry, but at the same time,...
  • Cortical Development: Genes and Genetic Abnormalities

    John Wiley and Sons Ltd, Jan 2008 , Pages: 304
    To understand the brain and its devastating diseases, we need to reveal the mechanisms that produce it and the ways in which it can constantly change throughout a lifetime.  This book features a timely...
  • Ethics, Law and Society - Volume 3

    Ashgate Publishing, Dec 2007 , Pages: 334
    The third volume in a series exploring key issues in ethics, law and society, published in association with the Cardiff Centre for Ethics, Law and Society This work presents a selection of papers and...
  • From Genes to Genomes: Concepts and Applications of DNA Technology, 2nd Edition

    John Wiley and Sons Ltd, Oct 2007 , Pages: 416
    “… an excellent book… achieves all of its goals with style, clarity and completeness… You can see the power and possibilities of molecular genetics as you read…” –Human Genetics "This volume hits an...
  • Gene Therapy-Industry Impact

    Frost & Sullivan, Dec 2006 , Pages: 125
    This Frost & Sullivan research service titled Advances in Gene Therapy provides an overview of the current developments and advanced technologies in gene therapy, along with a complete analysis of the...
  • Strategic Analysis of Thermal Cycler Markets in Europe

    Frost & Sullivan, Dec 2006 , Pages: 69
    This Frost & Sullivan research service titled Strategic Analysis of Thermal Cycler Markets in Europe provides an overview of current market trends and the future of thermal cycler markets The study...
  • Strategic Analysis of U.S. Genomics Markets

    Frost & Sullivan, Dec 2006
    This research service provides a strategic analysis of genomics markets within the United States The market was divided into the total U S nucleic acid isolation markets, total U S PCR markets, total...
  • U.S. DNA Sequencing Technology Markets

    Frost & Sullivan, Dec 2006 , Pages: 171
    This research service analyzes the market for DNA sequencing technologies within the United States The market was divided into the chain terminator sequencing and next generation sequencing segments...
  • U.S. Sequencing Services Markets

    Frost & Sullivan, Sep 2006
    This research service analyzes the market for sequencing services within the United States. The key challenges and strategies, market and technology trends, competitive structure, market share analysis,...
  • Has Genomics Failed to Deliver?

    Decision Resources, Inc, Jun 2006
    Following its conception more than a decade ago, the field of genomics excited the research community with the possibility of a faster, surer route to drug discovery, but this optimism has quickly faded...
  • Emerging Technologies: Stem Cells, Genes and Monoclonal Antibodies

    Centient Consulting, Inc, Jan 2006 , Pages: 19
    This report examines the three technological advances that are rapidly opening broad new avenues for drug development and therapeutics: monoclonal antibodies, gene manipulation and stem cells. The underlying...
  • Developments in Pharmacogenomics (Technical Insights)

    Frost & Sullivan, Dec 2005
    Pressure to Optimize Drug Discovery Drives Adoption Considering that the development of a single drug costs an average of $500 million and that only 30 percent of approved drugs even recover these costs,...
  • U.S. DNA Microarray Markets

    Frost & Sullivan, Dec 2005
    This Frost & Sullivan research service entitled U.S. DNA Microarrays Markets thoroughly examine the Arrays Markets, Consumables Markets, Instrumentations Markets, and Software Markets. Benefits of...
  • U.S. Gene Therapy Markets

    Frost & Sullivan, Sep 2005
    Growing Pressure for Results Renews Investor Interest in Gene Therapy Biotech companies in the United States are facing enormous pressure to develop a gene therapy approved for marketing. While China...
  • U.S. Genetic Diagnostics Markets

    Frost & Sullivan, Sep 2005
    Genetic Diagnostics Set to Revolutionize Healthcare Practices The increased understanding of the genetic basis of disease and genotype/phenotype correlation has allowed genetic diagnostics to become...
  • Genomics and Proteomics Markets in Australia

    Frost & Sullivan, Jun 2005
    Increasing Research Drives Genomics and Proteomics Market in Australia Extensive research in genomics and proteomics is promising cures for previously untreatable diseases. With the Government assisting...
  • World Gene Therapy Market

    Frost & Sullivan, May 2005
    Combination Trials in Gene Therapy Market to Improve Clinical Efficiency Recent failures of clinical trials in gene therapy have caused the termination of several research projects and the retraction...
Results: First - Prev - 1 - 2 - Next - Last